8-K: NewLake Capital Reports Strong 2025, Declares Q1 2026 Dividend

NewLake Capital Partners announced its fourth quarter and full-year 2025 financial results, reporting increased annual revenue and AFFO, and declared a $0.43 per share dividend for Q1 2026.

Summary

• Total revenue for the full year 2025 increased by 1.9% to $51.1 million, up from $50.1 million in 2024.
• Fourth quarter 2025 revenue was $12.3 million, a modest decline of 1.4% compared to $12.5 million in Q4 2024, primarily due to vacancies at properties previously leased to AYR Wellness, Inc. and Revolutionary Clinics, Inc.
• Net income attributable to common stockholders for the full year 2025 was $26.3 million, or $1.28 per share, a slight increase from $26.1 million, or $1.27 per share, in 2024.
• Adjusted Funds From Operations (AFFO) for the full year 2025 increased by 0.3% to $43.8 million, or $2.09 per share, compared to $43.7 million, or $2.08 per share, in 2024.
• Fourth quarter 2025 AFFO decreased by 3.0% to $10.6 million, or $0.51 per share, from $10.9 million, or $0.52 per share, in Q4 2024, also impacted by vacancies.
• The Board of Directors declared a first quarter 2026 cash dividend of $0.43 per share of common stock, equivalent to an annualized dividend of $1.72 per common share.
• The company purchased two dispensaries in Ohio for approximately $0.8 million and committed to fund approximately $1.1 million of improvements during 2025, funding $0.7 million as of December 31, 2025.
• A like-kind exchange was completed, transferring a dispensary in Mokena, IL for one in Brookville, PA.
• As of December 31, 2025, cash and cash equivalents were $23.9 million, with total liquidity of $106.3 million, including availability under its Revolving Credit Facility.
• Gross real estate assets stood at $432.9 million, with a low debt to total gross assets ratio of 1.6% and no debt maturities until May 2027.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a solid performance, with stable full-year growth and a strong dividend, underpinned by a robust balance sheet. While Q4 saw slight declines due to tenant issues, management's proactive approach and the positive industry outlook provide a favorable long-term perspective.

Positives

• Full-year 2025 revenue increased by 1.9% to $51.1 million, demonstrating overall growth.
• Full-year 2025 Adjusted Funds From Operations (AFFO) increased by 0.3% to $43.8 million, exceeding 2024 levels despite industry challenges.
• The company declared a consistent first quarter 2026 dividend of $0.43 per share, maintaining an annualized dividend of $1.72 per share.
• Dividend growth has been significant, increasing 79% since the company's initial public offering in 2021.
• Strong balance sheet with $23.9 million in cash and cash equivalents and total liquidity of $106.3 million as of December 31, 2025.
• Low debt to total gross assets ratio of 1.6% and no debt maturities until May 2027, indicating financial stability.
• The company maintains a quality portfolio with a 12-year weighted average remaining lease term and 2.6% annual rent escalations.
• The cannabis industry is positioned for sustained long-term growth, with projections of $54.1 billion by 2029, and increasing acceptance across the U.S. population.
• Potential federal catalysts, including the SAFER Banking Act, STATES Act, and the proposed rescheduling of cannabis from Schedule I to Schedule III, could significantly benefit the industry.

Negatives

• Fourth quarter 2025 revenue declined by 1.4% to $12.3 million compared to the same period in 2024.
• Fourth quarter 2025 Adjusted Funds From Operations (AFFO) decreased by 3.0% to $10.6 million compared to Q4 2024.
• The decline in Q4 revenue and AFFO was primarily driven by vacancies at two properties previously leased to AYR Wellness, Inc. and one property previously leased to Revolutionary Clinics, Inc.
• The company applied approximately $408 thousand of remaining AYR security deposits to rent, partially offsetting unpaid amounts, indicating tenant payment issues.

Risks

• Continued tenant dislocations across the industry pose a risk to rental income and property occupancy.
• Vacancies at properties previously leased to AYR Wellness, Inc. and Revolutionary Clinics, Inc. have already impacted Q4 2025 revenue and AFFO.
• The Cannabist Company, a tenant, is operating under a forbearance agreement with its senior noteholders, which has been extended through March 6, 2026, indicating potential financial distress for a key tenant.
• The company's lease agreements are subject to the performance of state-licensed cannabis operators, which can be influenced by regulatory changes, market competition, and economic conditions.
• The sale of the Hartford, CT property, while C3 Industries is required to reimburse for shortfalls below investment basis, still introduces uncertainty regarding the timing and proceeds of the sale.

Future Outlook

Management anticipates continued focus on disciplined portfolio management, advancing retenanting initiatives for vacant properties, and sourcing high-quality investment opportunities to drive long-term value for shareholders. The company expects to benefit from the sustained long-term growth of the cannabis industry, which is projected to reach $54.1 billion by 2029, driven by new state-level legalizations and potential federal reforms such as the SAFER Banking Act and the rescheduling of cannabis.

Management Comments

• "Our fourth quarter results were in line with expectations, delivering AFFO of $0.51 per share and an AFFO payout ratio of 85%."
• "Notably, our full-year performance exceeded 2024 levels, which is a meaningful accomplishment given the continued tenant dislocations across the industry."
• "As we look ahead to 2026, we are pleased to declare our first-quarter dividend of $0.43 per share."
• "Our team remains focused on disciplined portfolio management, advancing retenanting initiatives, and sourcing high-quality investment opportunities to drive long-term value for our shareholders."

Industry Context

StockSavvy.ai notes that NewLake Capital Partners operates within the dynamic and evolving U.S. cannabis real estate market, which is experiencing significant state-level expansion and growing public acceptance. The company's focus on providing real estate capital to state-licensed cannabis operators positions it to capitalize on the industry's projected growth from $40.5 billion in 2025 to $54.1 billion by 2029. Furthermore, potential federal legislative and administrative catalysts, such as the SAFER Banking Act, STATES Act, and the proposed rescheduling of cannabis, could significantly de-risk the sector and enhance access to traditional financing, potentially benefiting NewLake's tenants and investment opportunities. However, the industry still faces challenges, including tenant dislocations and the need for disciplined portfolio management, as evidenced by the forbearance agreement with The Cannabist Company.

Comparison to Industry Standards

• NewLake Capital Partners (NLCP) has an AFFO multiple of 7.5x, which is comparable to Innovative Industrial Properties (IIPR) at 7.8x, but significantly lower than Non-Cannabis REIT Peers (average 15.0x) and slightly above Cannabis Mortgage REIT/BDC Peers (average 6.3x).
• NLCP's dividend yield of 10.9% is competitive, falling between IIPR's 13.4% and Non-Cannabis REIT Peers' 4.8%, while being lower than Cannabis Mortgage REIT/BDC Peers' 17.6%.
• The company's Q4 Debt/Equity ratio of 1.9% is remarkably low compared to IIPR (21.3%), Non-Cannabis REIT Peers (average 84.1%), and Cannabis Mortgage REIT/BDC Peers (average 30.6%), indicating a very strong balance sheet and low leverage.
• NLCP's FY 2025 Payout Ratio of 82% is within its target range of 80-90% and compares favorably to IIPR's 105% (suggesting over-distribution) and Non-Cannabis REIT Peers' 71% (lower payout), while being below Cannabis Mortgage REIT/BDC Peers' 111% (also suggesting over-distribution).

Stakeholder Impact

• Shareholders are positively impacted by consistent dividend payments, which have grown 79% since the IPO, and the company's strong financial position and low leverage.
• Tenants, particularly those experiencing 'dislocations' or operating under forbearance agreements like The Cannabist Company, face operational and financial challenges, which could impact their lease obligations.
• Employees benefit from the company's stable operations and growth-oriented focus in a developing industry.
• Creditors are positively impacted by the company's low debt-to-asset ratio, high debt service coverage, and no near-term debt maturities, indicating strong creditworthiness.

Next Steps

• Management will host a conference call and webcast on March 6, 2026, at 11:00 a.m. Eastern Time to discuss the financial results.
• The first quarter 2026 cash dividend of $0.43 per share will be paid on April 15, 2026, to stockholders of record on March 31, 2026.
• The company will continue to focus on disciplined portfolio management, advancing retenanting initiatives for vacant properties.
• NewLake Capital Partners will continue sourcing high-quality investment opportunities to drive long-term value for shareholders.
• The company is actively marketing the Hartford, CT property for sale following an amended lease agreement with C3 Industries.

Key Dates

Recommendation

The company demonstrates stable financial performance with consistent dividends and a strong balance sheet, operating in a growing industry with potential federal catalysts. However, the slight Q4 revenue and AFFO decline, coupled with ongoing tenant dislocations and the forbearance agreement for a key tenant, introduce some near-term uncertainty. The stock appears attractive relative to some REIT peers but faces specific industry risks. A "hold" recommendation reflects the balance between these positive fundamentals and the inherent risks in the cannabis real estate sector.

Keywords

Cannabis real estate, REIT, NewLake Capital Partners, NLCP, Financial results, Dividend, FFO, AFFO, Cannabis industry, Real estate investment, Triple-net lease, Cannabis legalization, SEC filing